Analysis of the intestinal microbiome of a recovered clostridium difficile patient after fecal transplantation

Digestion

Volumn 88, Issue 4, 2013, Pages 243-251

  Broecker, Felix ^a,d,f   Kube, Michael ^d   Klumpp, Jochen ^b   Schuppler, Markus ^b   Biedermann, Luc ^c   Hecht, Jochen ^e   Hombach, Michael ^a   Keller, Peter M ^a,g   Rogler, Gerhard ^c   Moelling, Karin ^a,d,h  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d HUMBOLDT UNIVERSITY   (Germany)

^e Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^f MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^g JENA UNIVERSITY HOSPITAL   (Germany)

^h LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

Clostridium difficile; Clostridium difficile associated disease; Colitis; Fecal microbiota transplantation; Illumina; Metagenomics; Microbiome

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; CLINDAMYCIN; METRONIDAZOLE; RIFAMPICIN; RIFAXIMIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE DURATION; DRUG DOSE REDUCTION; FECAL TRANSPLANTATION; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HOSPITAL ADMISSION; HUMAN; INTESTINE FLORA; MEDICAL HISTORY; METAGENOMICS; MICROBIAL DIVERSITY; MICROBIOME; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; OPEN READING FRAME; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SACCHAROMYCES CEREVISIAE; TRANSPLANTATION; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; DNA, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HUMANS; INTESTINES; METAGENOMICS; MICROBIOTA; MIDDLE AGED; SEQUENCE ANALYSIS, DNA;

EID: 84892154530     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000355955     Document Type: Article

References (70)

1. Thomas C, Stevenson M, Riley TV: Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003; 51: 1339-1350.
2. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN: An epidemic, toxin genevariant strain of Clostridium difficile . N Engl J Med 2005; 353: 2433-2441.
3. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC: Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366: 1079-1084.
4. Rouphael NG, O'Donnell JA, Bhatnagar J, Lewis F, Polgreen PM, Beekmann S, Guarner J, Killgore GE, Coffman B, Campbell J, Zaki SR, McDonald LC: Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol 2008; 198: 635.e1-e6.
5. Zilberberg MD, Shorr AF, Kollef MH: Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14: 929-931.
6. Nylund CM, Goudie A, Garza JM, Fairbrother G, Cohen MB: Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011; 165: 451-457.
7. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH: The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23: 529-549.
8. Nelson R: Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 2007; 3: CD004610.
9. Drekonja DM, Butler M, MacDonald R, Bliss D, Filice GA, Rector TS, Wilt TJ: Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med 2011; 155: 839-847.
10. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-455.
11. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME: Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997; 24: 324-333.
12. O'Neill GL, Beaman MH, Riley TV: Relapse versus reinfection with Clostridium difficile . Epidemiol Infect 1991; 107: 627-635.
13. Wilcox MH, Spencer RC: Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect 1992; 22: 85-92.
14. Bakken JS: Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009; 15: 285-289.
15. Bowden TA Jr, Mansberger AR Jr, Lykins LE: Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 1981; 47: 178-183.
16. Eiseman B, Silen W, Bascom GS, Kauvar AJ: Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-859.
17. Grehan MJ, Borody TJ, Leis SM, Campbell J, Mitchell H, Wettstein A: Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44: 551-561.
18. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ: Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354-360.
19. Schwan A, Sjölin S, Trottestam U, Aronsson B: Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983;ii:845.
20. Silverman MS, Davis I, Pillai DR: Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol 2010; 8: 471-473.
21. Shahinas D, Silverman M, Sittler T, Chiu C, Kim P, Allen-Vercoe E, Weese S, Wong A, Low DE, Pillai DR: Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio 2012; 3:e00338-12.
22. Guo B, Harstall C, Louie T, Veldhuyzen van Zanten S, Dieleman LA: Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012; 35: 865-875.
23. Brandt LJ, Aroniadis OC: An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc 2013; 78: 240-249.
24. Rubin TA, Gessert CE, Aas J, Bakken JS: Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe 2013; 19: 22-26.
25. Suwantarat N, Bobak DA: Fecal bacteriotherapy for recurrent Clostridium difficile infection: what's old is new again? Curr Infect Dis Rep 2013; 15: 101-103.
26. Rohlke F, Stollman N: Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol 2012; 5: 403-420.
27. Brandt LJ: American Journal of Gastroenterology lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol 2013; 108: 177-185.
28. Kleger A, Schnell J, Essig A, Wagner M, Bommer M, Seufferlein T, Härter G: Fecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int 2013; 110: 108-115.
29. Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ: High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013; 4: 125-135.
30. Palmer R: Fecal matters. Nat Med 2011; 17: 150-152.
31. van Nood E, Speelman P, Kuijper EJ, Keller JJ: Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill 2009;14:pii = 19316.
32. Kassam Z, Lee CH, Yuan Y, Hunt RH: Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500-508.
33. Aas J, Gessert CE, Bakken JS: Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36: 580-585.
34. Grehan MJ, Borody TJ, Leis SM, Campbell J, Mitchell H, Wettstein A: Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44: 551-561.
35. Tvede M, Rask-Madsen J: Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1: 1156-1160.
36. Weingarden AR, Hamilton MJ, Sadowsky MJ, Khoruts A: Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation. J Clin Gastroenterol 2013; 47: 735-737.
37. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ: Duodenal infusion of donor feces for recurrent Clostridium difficile . N Engl J Med 2001; 368: 407-415.
38. Hecht DW: Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, Approved Standard, ed 7. Wayne, Clinical and Laboratory Standards Institute, 2007.
39. Johnson S, Schriever C, Galang M, Kelly CP, Gerding DN: Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 2007; 44: 846-848.
40. Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD Jr, Leney M, Sloan S, Hay CA, Ambrosino DM: Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010; 362: 197-205.
41. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; MetaHIT Consortium, Bork P, Ehrlich SD, Wang J: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
42. Marchesi JR: Prokaryotic and eukaryotic diversity of the human gut. Adv Appl Microbiol 2010; 72: 43-62.
43. Salzberg SL, Delcher AL, Kasif S, White O: Microbial gene identification using interpolated Markov models. Nucleic Acids Res 1998; 26: 544-548.
44. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990; 215: 403-410.
45. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW: GenBank. Nucleic Acids Res 2009; 37:D26-D31.
46. Huson DH, Auch AF, Qi J, Schuster SC: MEGAN analysis of metagenomic data. Genome Res 2007; 17: 377-386.
47. Wang X, Heazlewood SP, Krause DO, Florin TH: Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 2003; 95: 508-520.
48. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
49. van Passel MW, Kant R, Zoetendal EG, Plugge CM, Derrien M, Malfatti SA, Chain PS, Woyke T, Palva A, de Vos WM, Smidt H: The genome of Akkermansia muciniphila , a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One 2011; 6:e16876.
50. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, MetaHIT Consortium, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Mérieux A, Melo Minardi R, M'rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P: Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180.
51. Sharon I, Morowitz MJ, Thomas BC, Costello EK, Relman DA, Banfield JF: Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome Res 2013; 23: 111-120.
52. Savage DC: Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31: 107-133.
53. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE: Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.
54. Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, Buhler JD, Gordon JI: Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005; 307: 1955-1959.
55. Grundmann O: The gut microbiome and presystemic metabolism: current state and evolving research. J Drug Metab Toxicol 2010; 1: 105-111.
56. Ramotar K, Conly JM, Chubb H, Louie TJ: Production of menaquinones by intestinal anaerobes. J Infect Dis 1984; 150: 213-218.
57. Clavel T, Haller D: Bacteria-and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 2007; 13: 1153-1164.
58. Lee YK, Mazmanian SK: Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010; 330: 1768-1773.
59. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL: An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107-118.
60. Ley RE, Peterson DA, Gordon JI: Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837-848.
61. Pearson A: Historical and changing epidemiology of healthcare-associated infections. J Hosp Infect 2009; 73: 296-304.
62. Kahn SA, Vachon A, Rodriquez D, Goeppinger SR, Surma B, Marks J, Rubin DT: Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis 2013; 19: 1506-1513.
63. Kyne L, Farrell RJ, Kelly CP: Clostridium difficile . Gastroenterol Clin North Am 2001; 30: 753-777, ix-x.
64. Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, Takakuwa H, Saikai T, Kobayashi K, Yamagishi T, Nakamura S: Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 2001; 50: 720-727.
65. Mills S, Shanahan F, Stanton C, Hill C, Coffey A, Ross RP: Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 2013; 4: 4-16.
66. Lepage P, Colombet J, Marteau P, Sime-Ngando T, Doré J, Leclerc M: Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut 2008; 57: 424-425.
67. Reyes A, Haynes M, Hanson N, Angly FE, Heath AC, Rohwer F, Gordon JI: Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010; 466: 334-338.
68. Kunde S, Pham A, Bonczyk S, Teri C, Duba M, Conrad H Jr, Cloney D, Kugathasan S: Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 56: 597-601.
69. Damman CJ, Miller SI, Surawicz CM, Zisman TL: The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 2012; 107: 1452-1459.
70. de Leon LM, Watson JB, Kelly CR: Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 2013; 11: 1036-1038.